A team led by Reuben Harris, professor in the Department of Biochemistry, Molecular Biology, and Biophysics, and Douglas Yee, director of the Masonic Cancer Center, and professor in the Department of Medicine and Pharmacology, were recently awarded a P01 from NCI.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe